What better way to celebrate than to recognize Flatiron’s Pharmacy Community and introduce the first edition of our new quarterly newsletter, Pill Press.
You may already be subscribed to Curbside, our clinical newsletter. While those in the pharmacy field are also clinicians, we wanted to create a resource specifically for oncology pharmacists. In Pill Press and within our Pharmacy Community, we’ll share relevant product updates, industry observations, and other important pharmacy-related news. You can manage your Communities subscriptions here.
I hope each of you took a moment last month to celebrate all your hard work and the unique contributions you make as oncology pharmacists. From increasing practice revenue to improving medication adherence and reducing rates of hospital admissions, the oncology pharmacist is a key player in improving care for cancer patients.
Here at Flatiron, we’ve grown our Clinical Oncology team to include eight board-certified oncology pharmacists to match the growth and presence of oncology pharmacists in the Flatiron Network. These pharmacists are dedicated to building best-in-class clinical content and embedded product development support to ensure that we deliver safe and effective products to your clinics. Through Pill Press, we hope to highlight each of their unique perspectives and how they contribute to the pharmacist mission of ensuring optimal medication therapy outcomes.